EXHIBIT 10.9 ------------ FOURTH AMENDMENT ---------------- This Amendment with Effective Date of March 19, 1993 is to the License Agreement between M.I.T. and Matritech, Inc. with the Effective Date of December 14, 1989.Matritech Inc/De/ • March 27th, 1998 • In vitro & in vivo diagnostic substances
The parties thereto hereby agree that the time specified for completion of the milestone identified in paragraph 3.2(c) be extended until June 30, 1994.
EXHIBIT 10.21 DISTRIBUTORSHIP AGREEMENTDistributorship Agreement • March 27th, 1998 • Matritech Inc/De/ • In vitro & in vivo diagnostic substances • Pennsylvania
RECITALSSenior Loan and Security Agreement • March 27th, 1998 • Matritech Inc/De/ • In vitro & in vivo diagnostic substances • California
In accordance with our Development and Supply Agreement of September 1991, Paragraph 3.1 as well as our letter agreement of July 27, 1992, Matritech and Yamanouchi hereby agree to extend the estimated completion time for the 1st -- antibody pair until...Matritech Inc/De/ • March 27th, 1998 • In vitro & in vivo diagnostic substances
Dr. Tadashi Obara Diagnostic R&D Department Clinical Development Division Yamanouchi Pharmaceutical Co., Ltd. No. 1-6 Azusawa 1-chome Itabashi-ku Tokyo 174, Japan
